- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
NEW BRUNSWICK, N.J., USA: Johnson & Johnson has announced the resignation of its Chief Executive Officer William C. Weldon. The sixty-three year old is succeeded by Alex Gorsky, who currently serves as Vice Chairman of one of the company's Executive Committees, the vendor of Listerine mouthwash said. Reasons for Weldon's leaving were not given.
Weldon has been with Johnson & Johnson in different positions for over 40 years. He became CEO of the company in 2002. According to officials statements, he will remain Chairman of the company's board of directors.
J&J's stocks at the NASDAQ stock market were not affected by the news.
Under Weldon's leadership, J&J expanded significantly into other businesses with a number of aquisitions such as Pfizer's health consumer division in 2006 that included the popular Listerine mouthwash brand. As latest aquisition, the company bought the Swiss orthopaedic specialist company Synthes in April last year.
His last years as CEO were also overshadowed by corruption charges and a high number of product recalls that included four million bottles of Listerine Agent Cool Blue the company said to be contaminated with unspecified microorganisms, among others.
Gorsky's appointment as CEO will become effective at the company's next shareholder meeting in April this year.
Mon. 29 April 2024
12:30 PM EST (New York)
Root caries: The challenge in today’s cariology
Tue. 30 April 2024
1:00 PM EST (New York)
Neodent Discovery: Neoarch Guided Surgery—from simple to complex cases
Fri. 3 May 2024
1:00 PM EST (New York)
Osseointegration in extrēmus: Complex maxillofacial reconstruction & rehabilitation praeteritum, praesens et futurum
Tue. 7 May 2024
8:00 PM EST (New York)
You got this! Diagnosis and management of common oral lesions
Thu. 9 May 2024
8:00 PM EST (New York)
Empowering your restorative practice: A comprehensive guide to clear aligner integration and success
Mon. 13 May 2024
9:00 AM EST (New York)
CREATING MORE PRACTICE TIME THROUGH EFFICIENCY: IMPROVED ACCURACY AND DELEGATION
Mon. 13 May 2024
1:00 PM EST (New York)
To post a reply please login or register